Of Interest

Phase 3 clinical trials have confirmed superiority of dual immunotherapy over monotherapy in metastatic melanoma

For Melanoma Awareness Month, Andrew Pecora, MD, discussed melanoma prevention and treatment. Pecora emphasized the importance of lifelong UV protection, regular skin exams, and early detection.

The melanoma treatment landscape has evolved dramatically over the past decade with immunotherapy emerging as a frontline approach

Molecular testing enhances risk stratification and personalizes treatment plans for melanoma and SCC, surpassing traditional staging methods.